• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Hayward Holdings Reports First Quarter Fiscal Year 2025 Financial Results and Confirms 2025 Guidance

    5/1/25 7:01:00 AM ET
    $HAYW
    Industrial Machinery/Components
    Industrials
    Get the next $HAYW alert in real time by email

    FIRST QUARTER FISCAL 2025 SUMMARY

    • Net Sales increased 8% year-over-year to $228.8 million
    • Net Income increased 46% year-over-year to $14.3 million
    • Adjusted EBITDA* increased 9% year-over-year to $49.1 million
    • Diluted EPS increased 50% year-over-year to $0.06
    • Adjusted diluted EPS* increased 25% year-over-year to $0.10

    Hayward Holdings, Inc. (NYSE:HAYW) ("Hayward" or the "Company"), a global designer, manufacturer and marketer of a broad portfolio of pool and outdoor living technology, today announced financial results for the first quarter ended March 29, 2025 of its fiscal year 2025. Comparisons are to financial results for the prior-year first fiscal quarter.

    CEO COMMENTS

    "I am pleased to report solid first quarter results ahead of expectations," said Kevin Holleran, Hayward's President and Chief Executive Officer. "Net sales increased 8% year-over-year with growth across both the North America and Europe and Rest of World segments. Positive volume growth and price realization, coupled with robust profitability and working capital management, enabled us to maintain net leverage within our targeted range at 2.8x at the end of the first quarter while funding our growth strategies and launching innovative new products. During this period of increased tariffs and heightened global economic uncertainty, we are aggressively executing our plans to support profitability and position the Company for continued growth. With a resilient aftermarket model and strong balance sheet, we are confident in our ability to navigate this evolving environment."

    FIRST QUARTER FISCAL 2025 CONSOLIDATED RESULTS

    Net sales increased by 8% to $228.8 million for the first quarter of fiscal 2025. The increase in net sales during the quarter was the result of volume growth, the favorable impact from acquisitions and positive net price, partially offset by the unfavorable impact of foreign currency translation. The growth in volume was driven by the U.S. and Europe and the favorable timing of orders.

    Gross profit increased by 8% to $113.4 million for the first quarter of fiscal 2025. Gross profit margin increased 30 basis points to 49.5%. The increase in gross profit margin was due to positive net price.

    Selling, general, and administrative expense ("SG&A") increased by 9% to $65.1 million for the first quarter of fiscal 2025. The increase in SG&A was primarily due to normalized incentive compensation expense and investments in our customer-care and selling teams. As a percentage of net sales, SG&A increased 30 basis points to 28.5%, compared to the prior-year period of 28.2%, driven by the factors discussed above. Research, development, and engineering expenses were $6.0 million for the first quarter of fiscal 2025, or 3% of net sales, as compared to $6.3 million for the prior-year period, or 3% of net sales.

    Operating income increased by 9% to $33.5 million for the first quarter of fiscal 2025, due to the aggregated effects of the items described above. Operating income as a percentage of net sales ("operating margin") was 14.6% for the first quarter of fiscal 2025, a 10 basis point increase from the 14.5% operating margin in the prior-year period.

    Interest expense, net, decreased by 27% to $13.7 million for the first quarter of fiscal 2025 driven by reduced debt as a result of the repayment of the Incremental Term Loan B principal balance in April 2024 and lower interest rates.

    Income tax expense for the first quarter of fiscal 2025 was $4.3 million, for an effective tax rate of 23.3%, compared to income tax expense of $3.1 million, for an effective tax rate of 23.8%, for the prior-year period. The change in the effective tax rate was primarily due to a reduction in the foreign rate differential.

    Net income increased by 46% to $14.3 million for the first quarter of fiscal 2025. Net income margin expanded 170 basis points to 6.3%.

    Adjusted EBITDA* increased by 9% to $49.1 million for the first quarter of fiscal 2025 from $45.0 million in the prior-year period. Adjusted EBITDA margin* expanded 30 basis points to 21.5%.

    Diluted EPS increased by 50% to $0.06 for the first quarter of fiscal 2025. Adjusted diluted EPS* increased by 25% to $0.10 for the first quarter of fiscal 2025.

    FIRST QUARTER FISCAL 2025 SEGMENT RESULTS

    North America

    Net sales increased by 8% to $187.1 million for the first quarter of fiscal 2025. The increase was driven by the acquisition and successful integration of the ChlorKing business acquired in June 2024, positive net price and volume growth due to the timing of orders in the 2025 season.

    Segment income increased by 9% to $43.5 million for the first quarter of fiscal 2025. Adjusted segment income* increased by 12% to $50.7 million.

    Europe & Rest of World

    Net sales increased by 7% to $41.8 million for the first quarter of fiscal 2025. The increase was primarily due to volume growth and positive net price, partially offset by the unfavorable impact of foreign currency translation. The increase in volume is due to improved operational performance compared to the prior-year period.

    Segment income increased by 8% to $6.5 million for the first quarter of fiscal 2025. Adjusted segment income* increased by 10% to $7.0 million.

    BALANCE SHEET AND CASH FLOW

    As of March 29, 2025, Hayward had cash and cash equivalents of $181.3 million and approximately $216.7 million available for future borrowings under its revolving credit facilities. Cash flow used in operations for the three months ended March 29, 2025 of $5.9 million was a decrease of $71.4 million from the prior-year period cash used of $77.2 million. The decrease in cash used was primarily driven by the sale of $100.0 million of accounts receivable under the Receivables Purchase Agreement, partially offset by higher accounts receivable related to the Early Buy program.

    OUTLOOK

    Hayward is confirming its full year 2025 guidance, reflecting the implications of the current tariff environment and aggressive execution of mitigation action plans. For fiscal year 2025, Hayward continues to expect net sales of approximately $1.060 billion to $1.100 billion and Adjusted EBITDA* of $280 million to $290 million.

    Hayward is excited about the long-term dynamics of the pool industry. The installed base of pools increases every year, providing continued growth opportunities, and the Company benefits from favorable secular demand trends in outdoor living, sunbelt migration, and technology adoption. Hayward continues to leverage its competitive advantages and drive increasing adoption of its leading SmartPad™ pool equipment products both in new construction and the aftermarket, which has historically represented approximately 80% of net sales. Hayward is confident in its long-term outlook for profitable growth and robust cash flow generation, driven by its technology leadership, operational excellence, strong brand and installed base, and multi-channel capabilities.

    Please see the Forward-Looking Statements section of this release for a discussion of certain risks relevant to Hayward's outlook.

    CONFERENCE CALL INFORMATION

    Hayward will hold a conference call to discuss the results today, May 1, 2025 at 9:00 a.m. (ET).

    Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at https://investor.hayward.com/events-and-presentations/default.aspx. An earnings presentation will be posted to the Investor Relations section of the Company's website prior to the conference call.

    The conference call can also be accessed by dialing (877) 423-9813 or (201) 689-8573.

    For those unable to listen to the live conference call, a replay will be available approximately three hours after the call through the archived webcast on the Hayward website or by dialing (844) 512-2921 or (412) 317-6671. The access code for the replay is 13752897. The replay will be available until 11:59 p.m. Eastern Time on May 15, 2025.

    ABOUT HAYWARD HOLDINGS, INC.

    Hayward Holdings, Inc. (NYSE:HAYW) is a leading global designer and manufacturer of pool and outdoor living technology. With a mission to deliver exceptional products, outstanding service and innovative solutions to transform the experience of water, Hayward offers a full line of energy-efficient and sustainable residential and commercial pool equipment including pumps, heaters, sanitizers, filters, LED lighting, water features, and cleaners all digitally connected through Hayward's intuitive IoT-enabled SmartPad™.

    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

    This press release contains certain statements that are "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 (the "Act") and releases issued by the Securities and Exchange Commission (the "SEC"). Such forward-looking statements relating to Hayward are based on the beliefs of Hayward's management as well as assumptions made by, and information currently available to it. These forward-looking statements include, but are not limited to, statements about Hayward's strategies, plans, objectives, expectations, intentions, expenditures and assumptions and other statements contained in or incorporated by reference in this earnings release that are not historical facts. When used in this document, words such as "guidance," "outlook," "may," "will," "should," "could," "intend," "potential," "continue," "anticipate," "believe," "estimate," "expect," "plan," "target," "predict," "project," "seek" and similar expressions as they relate to Hayward are intended to identify forward-looking statements. Hayward believes that it is important to communicate its future expectations to its stockholders, and it therefore makes forward-looking statements in reliance upon the safe harbor provisions of the Act. However, there may be events in the future that Hayward is not able to accurately predict or control, and actual results may differ materially from the expectations it describes in its forward-looking statements.

    Examples of forward-looking statements include, among others, statements Hayward makes regarding: Hayward's 2025 guidance and outlook; business plans and objectives; general economic and industry trends; business prospects; future product development and acquisition strategies; future channel stocking levels; growth and expansion opportunities; operating results; and working capital and liquidity. The forward-looking statements in this earnings release are only predictions. Hayward may not achieve the plans, intentions or expectations disclosed in Hayward's forward-looking statements, and you should not place significant reliance on its forward-looking statements. Hayward has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. Moreover, neither Hayward nor any other person assumes responsibility for the accuracy and completeness of forward-looking statements taken from third-party industry and market reports.

    Important factors that could affect Hayward's future results and could cause those results or other outcomes to differ materially from those indicated in its forward-looking statements include the following: its relationships with and the performance of distributors, builders, buying groups, retailers and servicers who sell Hayward's products to pool owners; impacts on Hayward's business from the sensitivity of its business to seasonality and unfavorable economic business conditions; competition from national and global companies, as well as lower-cost manufacturers; the imposition, or threat of imposition, of tariffs and other trade restrictions could adversely affect Hayward's business, including as a result of an adverse impact on general economic conditions; Hayward's ability to develop, manufacture and effectively and profitably market and sell its new planned and future products; its ability to execute on its growth strategies and expansion opportunities; Hayward's exposure to credit risk on its accounts receivable, impacts on Hayward's business from political, regulatory, economic, trade, and other risks associated with operating foreign businesses, including risks associated with geopolitical conflict; its ability to maintain favorable relationships with suppliers and manage disruptions to its global supply chain and the availability of raw materials; Hayward's ability to identify emerging technological and other trends in its target end markets; failure of markets to accept new product introductions and enhancements; the ability to successfully identify, finance, complete and integrate acquisitions; its reliance on information technology systems and susceptibility to threats to those systems, including cybersecurity threats, and risks arising from its collection and use of personal information data; misuse of its technology-enabled products could lead to reduced sales, liability claims or harm to its reputation; the impact of product manufacturing disruptions, including as a result of catastrophic and other events beyond Hayward's control; regulatory changes and developments affecting Hayward's current and future products; volatility in currency exchange rates and interest rates; Hayward's ability to service its existing indebtedness and obtain additional capital to finance operations and its growth opportunities; Hayward's ability to establish, maintain and effectively enforce intellectual property protection for its products, as well as its ability to operate its business without infringing, misappropriating or otherwise violating the intellectual property rights of others; the impact of material cost and other inflation, including as a result of new or increased tariffs; Hayward's ability to attract and retain senior management and other qualified personnel; the impact of changes in laws, regulations and administrative policy, including those that limit U.S. tax benefits, impact trade agreements, or address the impacts of climate change; the outcome of litigation and governmental proceedings; uncertainties related to distribution channel inventory practices and its impact on Hayward's net sales volumes; Hayward's ability to realize cost savings from restructuring activities and other factors set forth in "Risk Factors" in Hayward's most recent Annual Report on Form 10-K.

    Many of these factors are macroeconomic in nature and are, therefore, beyond Hayward's control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, Hayward's actual results, performance or achievements may vary materially from those described in this earnings release as anticipated, believed, estimated, expected, intended, planned or projected. The forward-looking statements included in this earnings release are made only as of the date of this earnings release. Unless required by United States federal securities laws, Hayward neither intends nor assumes any obligation to update these forward-looking statements for any reason after the date of this earnings release to conform these statements to actual results or to changes in Hayward's expectations.

    *NON-GAAP FINANCIAL MEASURES

    This earnings release includes certain financial measures not presented in accordance with the generally accepted accounting principles in the United States ("GAAP") including adjusted net income, adjusted basic EPS, adjusted diluted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted segment income and adjusted segment income margin. These financial measures are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing the Company's financial results. Hayward believes these non-GAAP measures provide analysts, investors and other interested parties with additional insight into the underlying trends of its business and assist these parties in analyzing the Company's performance across reporting periods on a consistent basis by excluding items that it does not believe are indicative of its core operating performance, which allows for a better comparison against historical results and expectations for future performance. Management uses these non-GAAP measures to understand and compare operating results across reporting periods for various purposes including internal budgeting and forecasting, short and long-term operating planning, employee incentive compensation, and debt compliance. These measures should not be considered in isolation or as an alternative to net income, segment income or other measures of profitability, performance or financial condition under GAAP. You should be aware that the Company's presentation of these measures may not be comparable to similarly titled measures used by other companies, which may be defined and calculated differently. See the appendix for a reconciliation of historical non-GAAP measures to the most directly comparable GAAP measures.

    Reconciliation of full fiscal year 2025 adjusted EBITDA outlook to the comparable GAAP measure is not being provided, as Hayward does not currently have sufficient data to accurately estimate the variables and individual adjustments for such reconciliation. Adjusted EBITDA outlook for full year 2025 is calculated in a manner consistent with the historical presentation of this measure, as shown in the appendix.

    Hayward Holdings, Inc.

    Unaudited Condensed Consolidated Balance Sheets

    (In thousands)

     

     

    March 29, 2025

     

    December 31, 2024

    Assets

     

     

     

    Current assets

     

     

     

    Cash and cash equivalents

    $

    181,333

     

     

    $

    196,589

     

    Accounts receivable, net of allowances of $2,761 and $2,701, respectively

     

    293,809

     

     

     

    278,582

     

    Inventories, net

     

    233,165

     

     

     

    216,472

     

    Prepaid expenses

     

    14,140

     

     

     

    20,203

     

    Income tax receivable

     

    1,279

     

     

     

    6,426

     

    Other current assets

     

    49,773

     

     

     

    48,697

     

    Total current assets

     

    773,499

     

     

     

    766,969

     

    Property, plant, and equipment, net of accumulated depreciation of $118,434 and $112,099, respectively

     

    158,806

     

     

     

    160,377

     

    Goodwill

     

    945,655

     

     

     

    943,645

     

    Trademark

     

    736,000

     

     

     

    736,000

     

    Customer relationships, net

     

    193,260

     

     

     

    198,333

     

    Other intangibles, net

     

    93,597

     

     

     

    96,095

     

    Other non-current assets

     

    83,780

     

     

     

    89,205

     

    Total assets

    $

    2,984,597

     

     

    $

    2,990,624

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities

     

     

     

    Current portion of long-term debt

    $

    13,637

     

     

    $

    13,991

     

    Accounts payable

     

    95,381

     

     

     

    81,476

     

    Accrued expenses and other liabilities

     

    185,355

     

     

     

    217,242

     

    Income taxes payable

     

    —

     

     

     

    273

     

    Total current liabilities

     

    294,373

     

     

     

    312,982

     

    Long-term debt, net

     

    950,376

     

     

     

    950,562

     

    Deferred tax liabilities, net

     

    236,945

     

     

     

    239,111

     

    Other non-current liabilities

     

    63,524

     

     

     

    64,322

     

    Total liabilities

     

    1,545,218

     

     

     

    1,566,977

     

     

     

     

     

    Stockholders' equity

     

     

     

    Preferred stock, $0.001 par value, 100,000,000 authorized, no shares issued or outstanding as of March 29, 2025 and December 31, 2024

     

    —

     

     

     

    —

     

    Common stock $0.001 par value, 750,000,000 authorized; 244,870,506 issued and 216,204,137 outstanding at March 29, 2025; 244,444,889 issued and 215,778,520 outstanding at December 31, 2024

     

    245

     

     

     

    245

     

    Additional paid-in capital

     

    1,096,819

     

     

     

    1,093,468

     

    Common stock in treasury; 28,666,369 and 28,666,369 at March 29, 2025 and December 31, 2024, respectively

     

    (359,126

    )

     

     

    (358,133

    )

    Retained earnings

     

    713,897

     

     

     

    699,564

     

    Accumulated other comprehensive income

     

    (12,456

    )

     

     

    (11,497

    )

    Total stockholders' equity

     

    1,439,379

     

     

     

    1,423,647

     

    Total liabilities, redeemable stock, and stockholders' equity

    $

    2,984,597

     

     

    $

    2,990,624

     

    Hayward Holdings, Inc.

    Unaudited Condensed Consolidated Statements of Operations

    (Dollars in thousands, except per share data)

     

     

    Three Months Ended

     

    March 29, 2025

     

    March 30, 2024

    Net sales

    $

    228,841

     

    $

    212,569

     

    Cost of sales

     

    115,466

     

     

    107,990

     

    Gross profit

     

    113,375

     

     

    104,579

     

    Selling, general and administrative expense

     

    65,117

     

     

    60,014

     

    Research, development and engineering expense

     

    5,986

     

     

    6,302

     

    Acquisition and restructuring related expense

     

    1,926

     

     

    504

     

    Amortization of intangible assets

     

    6,835

     

     

    6,900

     

    Operating income

     

    33,511

     

     

    30,859

     

    Interest expense, net

     

    13,651

     

     

    18,592

     

    Other expense (income), net

     

    1,179

     

     

    (638

    )

    Total other expense

     

    14,830

     

     

    17,954

     

    Income from operations before income taxes

     

    18,681

     

     

    12,905

     

    Provision for income taxes

     

    4,348

     

     

    3,065

     

    Net income

    $

    14,333

     

    $

    9,840

     

     

     

     

     

    Earnings per share

     

     

     

    Basic

    $

    0.07

     

    $

    0.05

     

    Diluted

    $

    0.06

     

    $

    0.04

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

    Basic

     

    215,962,018

     

     

    214,357,439

     

    Diluted

     

    221,851,399

     

     

    221,076,443

     

    Hayward Holdings, Inc.

    Unaudited Condensed Consolidated Statements of Cash Flows

    (In thousands)

    Three Months Ended

    March 29, 2025

     

    March 30, 2024

    Cash flows from operating activities

     

     

     

    Net income

    $

    14,333

     

     

    $

    9,840

     

    Adjustments to reconcile net income to net cash used in operating activities

     

     

     

    Depreciation

     

    6,263

     

     

     

    4,310

     

    Amortization of intangible assets

     

    8,535

     

     

     

    8,543

     

    Amortization of deferred debt issuance fees

     

    837

     

     

     

    1,180

     

    Stock-based compensation

     

    2,935

     

     

     

    1,983

     

    Deferred income taxes

     

    (709

    )

     

     

    (1,083

    )

    Allowance for bad debts

     

    (5

    )

     

     

    150

     

    (Gain) loss on sale of property, plant and equipment

     

    11

     

     

     

    (40

    )

    Changes in operating assets and liabilities

     

     

     

    Accounts receivable

     

    (13,931

    )

     

     

    (81,753

    )

    Inventories

     

    (14,977

    )

     

     

    (7,087

    )

    Other current and non-current assets

     

    7,918

     

     

     

    9,743

     

    Accounts payable

     

    13,519

     

     

     

    7,364

     

    Accrued expenses and other liabilities

     

    (30,579

    )

     

     

    (30,354

    )

    Net cash used in operating activities

     

    (5,850

    )

     

     

    (77,204

    )

     

     

     

     

    Cash flows from investing activities

     

     

     

    Purchases of property, plant, and equipment

     

    (5,517

    )

     

     

    (5,422

    )

    Software development costs

     

    (595

    )

     

     

    (510

    )

    Proceeds from sale of property, plant, and equipment

     

    1

     

     

     

    47

     

    Proceeds from short-term investments

     

    —

     

     

     

    25,000

     

    Net cash (used in) provided by investing activities

     

    (6,111

    )

     

     

    19,115

     

     

     

     

     

    Cash flows from financing activities

     

     

     

    Proceeds from issuance of long-term debt

     

    —

     

     

     

    2,194

     

    Payments of long-term debt

     

    (590

    )

     

     

    (3,230

    )

    Payments of short-term notes payable

     

    (1,788

    )

     

     

    (1,719

    )

    Purchase of common stock

     

    (993

    )

     

     

    (355

    )

    Other, net

     

    (364

    )

     

     

    28

     

    Net cash used in financing activities

     

    (3,735

    )

     

     

    (3,082

    )

     

     

     

     

    Effect of exchange rate changes on cash and cash equivalents

     

    440

     

     

     

    (1,053

    )

    Change in cash and cash equivalents

     

    (15,256

    )

     

     

    (62,224

    )

    Cash and cash equivalents, beginning of period

     

    196,589

     

     

     

    178,097

     

    Cash and cash equivalents, end of period

    $

    181,333

     

     

    $

    115,873

     

     

     

     

     

    Supplemental disclosures of cash flow information:

     

     

     

    Cash paid-interest

    $

    9,826

     

     

    $

    19,002

     

    Cash paid-income taxes

     

    151

     

     

     

    109

     

     

     

     

     

    Non-cash investing and financing activities:

     

     

     

    Accrued and unpaid purchases of property, plant, and equipment

    $

    2,232

     

     

    $

    1,102

     

    Equipment financed under finance leases

     

    103

     

     

     

    132

     

    Reconciliations

    Consolidated Reconciliations

    Adjusted EBITDA and Adjusted EBITDA Margin Reconciliations (Non-GAAP)

    Following is a reconciliation from net income to adjusted EBITDA:

     

    (Dollars in thousands)

    Three Months Ended

     

    March 29, 2025

     

    March 30, 2024

    Net income

    $

    14,333

     

     

    $

    9,840

     

    Depreciation

     

    6,263

     

     

     

    4,310

     

    Amortization

     

    8,535

     

     

     

    8,543

     

    Interest expense, net

     

    13,651

     

     

     

    18,592

     

    Income taxes

     

    4,348

     

     

     

    3,065

     

    EBITDA

     

    47,130

     

     

     

    44,350

     

    Stock-based compensation (a)

     

    46

     

     

     

    190

     

    Currency exchange items (b)

     

    (6

    )

     

     

    54

     

    Acquisition and restructuring related expense, net (c)

     

    1,926

     

     

     

    504

     

    Other (d)

     

    6

     

     

     

    (57

    )

    Total Adjustments

     

    1,972

     

     

     

    691

     

    Adjusted EBITDA

    $

    49,102

     

     

    $

    45,041

     

     

     

     

     

    Net income margin

     

    6.3

    %

     

     

    4.6

    %

    Adjusted EBITDA margin

     

    21.5

    %

     

     

    21.2

    %

    (a)

     

    Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of Hayward's initial public offering (the "IPO").

    (b)

     

    Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts.

    (c)

     

    Adjustments in the three months ended March 29, 2025 are primarily driven by $1.7 million of transaction and integration costs associated with the acquisition of the ChlorKing business and $0.2 million of separation costs for the consolidation of operations in North America.

     

    Adjustments in the three months ended March 30, 2024 are primarily driven by $0.4 million of separation and other costs associated with the centralization of operations in Europe.

    (d)

     

    Adjustments in the three months ended March 29, 2025 are primarily driven by losses on the sale of assets.

     

    Adjustments in the three months ended March 30, 2024 are primarily driven by gains on the sale of assets, partially offset by costs incurred related to litigation.

    Following is a reconciliation from net income to adjusted EBITDA for the last twelve months:

     

    (Dollars in thousands)

    Last Twelve Months(e)

     

    Fiscal Year

     

    March 29, 2025

     

    December 31, 2024

    Net income

    $

    123,148

     

     

    $

    118,655

     

    Depreciation

     

    22,031

     

     

     

    20,078

     

    Amortization

     

    35,775

     

     

     

    35,783

     

    Interest expense, net

     

    57,222

     

     

     

    62,163

     

    Income taxes

     

    26,810

     

     

     

    25,527

     

    Loss on debt extinguishment

     

    4,926

     

     

     

    4,926

     

    EBITDA

     

    269,912

     

     

     

    267,132

     

    Stock-based compensation (a)

     

    464

     

     

     

    608

     

    Currency exchange items (b)

     

    (896

    )

     

     

    (836

    )

    Acquisition and restructuring related expense, net (c)

     

    7,886

     

     

     

    6,464

     

    Other (d)

     

    4,142

     

     

     

    4,079

     

    Total Adjustments

     

    11,596

     

     

     

    10,315

     

    Adjusted EBITDA

    $

    281,508

     

     

    $

    277,447

     

     

     

     

     

    Net income margin

     

    11.5

    %

     

     

    11.3

    %

    Adjusted EBITDA margin

     

    26.4

    %

     

     

    26.4

    %

    (a)

     

    Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO.

    (b)

     

    Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts.

    (c)

     

    Adjustments in the last twelve months ended March 29, 2025 primarily include $4.7 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $4.7 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow will be released to the specified key employees if such employees are employed by Hayward on the one-year anniversary of the acquisition. These payments are contingent on continued employment and are not dependent on the achievement of any metric or performance measure. The retention costs will be recognized over the twelve-month period from the date of acquisition. Further, other adjustments include $1.3 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.4 million of costs to finalize restructuring actions initiated in prior years, $0.3 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.2 million of separation costs associated with the consolidation of operations in North America.

     

    Adjustments in the year ended December 31, 2024 are primarily driven by $3.2 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow will be released to the specified key employees if such employees are employed by Hayward on the one-year anniversary of the acquisition. These payments are contingent on continued employment and are not dependent on the achievement of any metric or performance measure. The retention costs will be recognized over the twelve-month period from the date of acquisition. Further, other adjustments for the year ended December 31, 2024 include $1.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.8 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize restructuring actions initiated in prior years.

    (d)

     

    Adjustments in the last twelve months ended March 29, 2025 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.4 million of gains on the sale of assets.

     

    Adjustments in the year ended December 31, 2024 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets.

    (e)

     

    Items for the last twelve months ended March 29, 2025 are calculated by adding the items for the three months ended March 29, 2025 plus fiscal year ended December 31, 2024 and subtracting the items for the three months ended March 30, 2024.

    Adjusted Net Income and Adjusted EPS Reconciliation (Non-GAAP)

    Following is a reconciliation of net income to adjusted net income and earnings per share to adjusted earnings per share:

     

    (Dollars in thousands, except per share data)

    Three Months Ended

     

    March 29, 2025

     

    March 30, 2024

    Net income

    $

    14,333

     

     

    $

    9,840

     

    Tax adjustments (a)

     

    (182

    )

     

     

    (147

    )

    Other adjustments and amortization:

     

     

     

    Stock-based compensation (b)

     

    46

     

     

     

    190

     

    Currency exchange items (c)

     

    (6

    )

     

     

    54

     

    Acquisition and restructuring related expense, net (d)

     

    1,926

     

     

     

    504

     

    Other (e)

     

    6

     

     

     

    (57

    )

    Total other adjustments

     

    1,972

     

     

     

    691

     

    Amortization

     

    8,535

     

     

     

    8,543

     

    Tax effect (f)

     

    (2,548

    )

     

     

    (2,298

    )

    Adjusted net income

    $

    22,110

     

     

    $

    16,629

     

     

     

     

     

    Weighted average number of common shares outstanding, basic

     

    215,962,018

     

     

     

    214,357,439

     

    Weighted average number of common shares outstanding, diluted

     

    221,851,399

     

     

     

    221,076,443

     

     

     

     

     

    Basic EPS

    $

    0.07

     

     

    $

    0.05

     

    Diluted EPS

    $

    0.06

     

     

    $

    0.04

     

     

     

     

     

    Adjusted basic EPS

    $

    0.10

     

     

    $

    0.08

     

    Adjusted diluted EPS

    $

    0.10

     

     

    $

    0.08

     

    (a)

     

    Tax adjustments for the three months ended March 29, 2025 reflect a normalized tax rate of 24.3% compared to the Company's effective tax rate of 23.3%. The Company's effective tax rate for the three months ended March 29, 2025 primarily includes the tax benefits resulting from stock compensation. Tax adjustments for the three months ended March 30, 2024 reflect a normalized tax rate of 24.9% compared to the Company's effective tax rate of 23.8%. The Company's effective tax rate for the three months ended March 30, 2024 includes the tax benefits resulting from stock compensation.

    (b)

     

    Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO.

    (c)

     

    Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts.

    (d)

     

    Adjustments in the three months ended March 29, 2025 are primarily driven by $1.7 million of transaction and integration costs associated with the acquisition of the ChlorKing business and $0.2 million of separation costs for the consolidation of operations in North America.

     

    Adjustments in the three months ended March 30, 2024 are primarily driven by $0.4 million of separation and other costs associated with the centralization of operations in Europe.

    (e)

     

    Adjustments in the three months ended March 29, 2025 are primarily driven by losses on the sale of assets.

     

    Adjustments in the three months ended March 30, 2024 are primarily driven by gains on the sale of assets, partially offset by costs incurred related to litigation.

    (f)

     

    The tax effect represents the immediately preceding adjustments at the normalized tax rates as discussed in footnote (a) above.

    Segment Reconciliations

    Following is a reconciliation from segment income to adjusted segment income for the North America ("NAM") and Europe & Rest of World ("E&RW") segments:

     

    (Dollars in thousands)

    Three Months Ended

     

    Three Months Ended

     

    March 29, 2025

     

    March 30, 2024

     

    NAM

     

    E&RW

     

    NAM

     

    E&RW

    Segment income

    $

    43,454

     

     

    $

    6,538

     

     

    $

    39,742

     

     

    $

    6,036

     

    Depreciation

     

    5,500

     

     

     

    414

     

     

    $

    3,887

     

     

    $

    257

     

    Amortization

     

    1,700

     

     

     

    —

     

     

    $

    1,643

     

     

     

    —

     

    Stock-based compensation

     

    —

     

     

     

    —

     

     

     

    12

     

     

     

    10

     

    Other (a)

     

    3

     

     

     

    —

     

     

     

    19

     

     

     

    —

     

    Total adjustments

     

    7,203

     

     

     

    414

     

     

     

    5,561

     

     

     

    267

     

    Adjusted segment income

    $

    50,657

     

     

    $

    6,952

     

     

    $

    45,303

     

     

    $

    6,303

     

     

     

     

     

     

     

     

     

    Segment income margin %

     

    23.2

    %

     

     

    15.7

    %

     

     

    22.9

    %

     

     

    15.4

    %

    Adjusted segment income margin %

     

    27.1

    %

     

     

    16.6

    %

     

     

    26.1

    %

     

     

    16.1

    %

    (a)

     

    The three months ended March 29, 2025 and March 30, 2024 represents losses on the sale of assets, which the Company believes are not representative of its ongoing business operations.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250501174200/en/

    Investor Relations:

    Kevin Maczka

    [email protected]

    Media Relations:

    Misty Zelent

    [email protected]

    Source: Hayward Holdings, Inc.

    Get the next $HAYW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HAYW

    DatePrice TargetRatingAnalyst
    4/3/2025Outperform → Peer Perform
    Wolfe Research
    2/5/2025$16.50Hold → Buy
    Stifel
    1/6/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    1/11/2024$15.00 → $14.00Buy → Hold
    Jefferies
    12/20/2023$13.00 → $13.50Buy → Hold
    Stifel
    8/3/2023$14.00 → $16.50Hold → Buy
    Stifel
    2/6/2023$11.00 → $13.00Buy → Hold
    Stifel
    1/4/2023$9.50 → $15.00Hold → Buy
    Jefferies
    More analyst ratings